--- title: "Aveanna Healthcare | 10-Q: FY2027 Q1 Revenue Misses Estimate at USD 647.92 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/286404000.md" datetime: "2026-05-14T11:03:17.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286404000.md) - [en](https://longbridge.com/en/news/286404000.md) - [zh-HK](https://longbridge.com/zh-HK/news/286404000.md) --- # Aveanna Healthcare | 10-Q: FY2027 Q1 Revenue Misses Estimate at USD 647.92 M Revenue: As of FY2027 Q1, the actual value is USD 647.92 M, missing the estimate of USD 658.18 M. EPS: As of FY2027 Q1, the actual value is USD 0.19, beating the estimate of USD 0.14. EBIT: As of FY2027 Q1, the actual value is USD 96.83 M. #### Segmented Financial Metrics ##### Private Duty Services (PDS) - **Revenue**: $535,652 thousand for the three-month period ended April 4, 2026, an increase of 16.4% from $459,998 thousand for the three-month period ended March 29, 2025. - **Cost of Revenue (excluding depreciation and amortization)**: $386,417 thousand for the three-month period ended April 4, 2026, an increase of 18.8% from $325,313 thousand for the three-month period ended March 29, 2025. - **Gross Margin**: $149,235 thousand for the three-month period ended April 4, 2026, an increase of 10.8% from $134,685 thousand for the three-month period ended March 29, 2025. - **Gross Margin Percentage**: 27.9% for the three-month period ended April 4, 2026, a decrease of -1.4% from 29.3% for the three-month period ended March 29, 2025. - **Hours**: 12,056 thousand for the three-month period ended April 4, 2026, an increase of 10.7% from 10,887 thousand for the three-month period ended March 29, 2025. - **Revenue Rate**: $44.43 for the three-month period ended April 4, 2026, an increase of 5.7% from $42.25 for the three-month period ended March 29, 2025. - **Cost of Revenue Rate**: $32.05 for the three-month period ended April 4, 2026, an increase of 8.1% from $29.88 for the three-month period ended March 29, 2025. - **Spread Rate**: $12.38 for the three-month period ended April 4, 2026, an increase of 0.1% from $12.37 for the three-month period ended March 29, 2025. ##### Home Health & Hospice (HHH) - **Revenue**: $66,609 thousand for the three-month period ended April 4, 2026, an increase of 17.4% from $56,733 thousand for the three-month period ended March 29, 2025. - **Cost of Revenue (excluding depreciation and amortization)**: $30,833 thousand for the three-month period ended April 4, 2026, an increase of 18.6% from $25,993 thousand for the three-month period ended March 29, 2025. - **Gross Margin**: $35,776 thousand for the three-month period ended April 4, 2026, an increase of 16.4% from $30,740 thousand for the three-month period ended March 29, 2025. - **Gross Margin Percentage**: 53.7% for the three-month period ended April 4, 2026, a decrease of -0.5% from 54.2% for the three-month period ended March 29, 2025. - **Home Health Total Admissions**: 11.0 thousand for the three-month period ended April 4, 2026, an increase of 13.4% from 9.7 thousand for the three-month period ended March 29, 2025. - **Home Health Episodic Admissions**: 8.9 thousand for the three-month period ended April 4, 2026, an increase of 18.7% from 7.5 thousand for the three-month period ended March 29, 2025. - **Home Health Total Episodes**: 14.9 thousand for the three-month period ended April 4, 2026, an increase of 23.1% from 12.1 thousand for the three-month period ended March 29, 2025. - **Home Health Episodic Mix**: 80.9% for the three-month period ended April 4, 2026, an increase of 3.6% from 77.3% for the three-month period ended March 29, 2025. - **Home Health Revenue Per Completed Episode**: $3,167 for the three-month period ended April 4, 2026, an increase of 0.5% from $3,152 for the three-month period ended March 29, 2025. ##### Medical Solutions (MS) - **Revenue**: $45,654 thousand for the three-month period ended April 4, 2026, an increase of 7.4% from $42,493 thousand for the three-month period ended March 29, 2025. - **Cost of Revenue (excluding depreciation and amortization)**: $25,237 thousand for the three-month period ended April 4, 2026, an increase of 3.6% from $24,360 thousand for the three-month period ended March 29, 2025. - **Gross Margin**: $20,417 thousand for the three-month period ended April 4, 2026, an increase of 12.6% from $18,133 thousand for the three-month period ended March 29, 2025. - **Gross Margin Percentage**: 44.7% for the three-month period ended April 4, 2026, an increase of 2.0% from 42.7% for the three-month period ended March 29, 2025. - **Unique Patients Served (UPS)**: 93 thousand for the three-month period ended April 4, 2026, an increase of 4.5% from 89 thousand for the three-month period ended March 29, 2025. - **Revenue Rate**: $490.90 for the three-month period ended April 4, 2026, an increase of 2.9% from $477.45 for the three-month period ended March 29, 2025. - **Cost of Revenue Rate**: $271.37 for the three-month period ended April 4, 2026, a decrease of -0.9% from $273.71 for the three-month period ended March 29, 2025. - **Spread Rate**: $219.53 for the three-month period ended April 4, 2026, an increase of 8.1% from $203.74 for the three-month period ended March 29, 2025. #### Consolidated Operational Metrics - **Operating Income**: $69,326 thousand for the three-month period ended April 4, 2026, an increase of 33.8% from $51,801 thousand for the three-month period ended March 29, 2025. - **Branch and Regional Administrative Expenses**: $95,792 thousand for the three-month period ended April 4, 2026, an increase of 4.8% from $91,387 thousand for the three-month period ended March 29, 2025. - **Corporate Expenses**: $34,156 thousand for the three-month period ended April 4, 2026, a decrease of -8.9% from $37,505 thousand for the three-month period ended March 29, 2025. - **Depreciation and Amortization**: $3,044 thousand for the three-month period ended April 4, 2026, an increase of 17.3% from $2,594 thousand for the three-month period ended March 29, 2025. - **Acquisition-related Costs**: $3,110 thousand for the three-month period ended April 4, 2026, compared to $106 thousand for the three-month period ended March 29, 2025. - **Other Operating Expense**: $0 thousand for the three-month period ended April 4, 2026, compared to $165 thousand for the three-month period ended March 29, 2025. - **Interest Expense, Net**: - $27,500 thousand for the three-month period ended April 4, 2026, compared to - $36,203 thousand for the three-month period ended March 29, 2025. - **Other Income (Expense)**: $3,149 thousand for the three-month period ended April 4, 2026, compared to - $5,450 thousand for the three-month period ended March 29, 2025. - **Income Tax Expense**: - $3,322 thousand for the three-month period ended April 4, 2026, compared to - $4,955 thousand for the three-month period ended March 29, 2025. - **Net Income**: $41,653 thousand for the three-month period ended April 4, 2026, an increase of 702.1% from $5,193 thousand for the three-month period ended March 29, 2025. - **Field Contribution**: $109,636 thousand for the three-month period ended April 4, 2026, an increase of 18.9% from $92,171 thousand for the three-month period ended March 29, 2025. - **Field Contribution Margin**: 16.9% for the three-month period ended April 4, 2026, an increase of 0.4% from 16.5% for the three-month period ended March 29, 2025. #### Cash Flow - **Net Cash Provided by (Used in) Operating Activities**: $4,349 thousand provided for the three-month period ended April 4, 2026, compared to - $8,632 thousand used for the three-month period ended March 29, 2025. - **Net Cash Used in Investing Activities**: - $4,557 thousand for the three-month period ended April 4, 2026, compared to - $2,348 thousand for the three-month period ended March 29, 2025. - **Net Cash Used in Financing Activities**: - $3,778 thousand for the three-month period ended April 4, 2026, compared to - $1,814 thousand for the three-month period ended March 29, 2025. - **Cash and Cash Equivalents at End of Period**: $189,274 thousand as of April 4, 2026, compared to $71,494 thousand as of March 29, 2025. - **Cash Paid for Interest**: $27,868 thousand for the three-month period ended April 4, 2026, compared to $34,911 thousand for the three-month period ended March 29, 2025. - **Cash Paid for Income Taxes, Net of Refunds Received**: - $11 thousand for the three-month period ended April 4, 2026, compared to - $460 thousand for the three-month period ended March 29, 2025. - **Days Sales Outstanding (DSO)**: 45.4 days as of April 4, 2026, compared to 45.6 days as of March 29, 2025. #### Liquidity and Indebtedness - **Cash on Hand**: $189.3 million as of April 4, 2026. - **Securitization Facility Availability**: $110.0 million available as of April 4, 2026. - **2025 Refinancing Revolving Credit Facility Borrowing Capacity**: Approximately $225.5 million available as of April 4, 2026. - **Total Indebtedness**: $1,483,375 thousand as of April 4, 2026, compared to $1,486,687 thousand as of January 3, 2026. - **Weighted Average Interest Rate**: 7.3% as of April 4, 2026 and January 3, 2026. #### Future Outlook and Strategy Aveanna Healthcare Holdings Inc. has a pending acquisition of Family First Holding, LLC for $175.5 million, expected to close in the second fiscal quarter of 2026, which will be funded by cash on hand and Securitization Facility borrowings. The company anticipates that its operating cash flows, available cash, and credit facilities will sufficiently cover cash requirements for at least the next twelve months. Additionally, Aveanna Healthcare Holdings Inc. entered an interest rate cap agreement for $520.0 million at a 4.00% cap rate, effective July 1, 2026, and maturing on December 31, 2029, to replace expiring swap agreements. ### Related Stocks - [AVAH.US](https://longbridge.com/en/quote/AVAH.US.md) ## Related News & Research - [Aveanna Healthcare Q1 revenue beats on PDS unit strength](https://longbridge.com/en/news/286405899.md) - [Aveanna Healthcare Issues 2026 Outlook, Highlights Growth](https://longbridge.com/en/news/286570705.md) - [Aveanna posts May 2026 investor presentation outlining $2.56-2.58B guidance and $84.4M Q1 adjusted EBITDA](https://longbridge.com/en/news/286566524.md) - [Aveanna Healthcare Stock Is Up 23%. Here’s Why a Fund Still Sold $16 Million Worth](https://longbridge.com/en/news/285841693.md) - [Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/281618667.md)